44 results
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
18 Aug 21
Current report (foreign)
12:20pm
at the Department of Sports Medicine at Nara Medical University, Dr. Kumai has been involved in education and research in sports medicine … Biology and Sports Medicine Research Lab at the University of Wales, UK, and the Department of Anatomy at the University of Munich, Germany, he now focuses
6-K
EX-99.3
REPCF
Replicel Life Sciences Inc.
18 Aug 21
Current report (foreign)
12:20pm
regenerative cell therapy products.
About Professor Youwen Zhou, M.D., Ph.D.
Dr. Youwen Zhou is a physician scientist who is a Professor at UBC’s Department … . Previously, he was an Associate Professor in the Department of Dermatology and Skin Health at the University of British Columbia, and Director
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
17 Jul 14
RepliCel Appoints Brooke Hurford as Corporate Secretary and Director, Finance
12:00am
department at the Bank of Montreal.
Pursuant to its Stock Option Plan, the Company granted 30,000 options to Ms. Hurford. The options vest over a one year
6-K
EX-1
REPCF
Replicel Life Sciences Inc.
2 Jul 03
Current report (foreign)
12:00am
of proxy is delivered to the office of CIBC Mellon Trust Company, by fax to 416.368.2502 or by mail or by hand to Proxy Department, 200 Queens Quay E
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
6 Nov 18
RepliCel Life Sciences Appoints Head of Clinical and Regulatory Affairs
11:03am
at their Department of Experimental Medicine. Her work experience includes industry leaders such as Pfizer and Ratiopharm. Since 2012, Dr. Goessens-Rueck has been
6-K
EX-99.3
ianzn3j2
21 Dec 21
51-102F3 Material Change Report
5:28pm
6-K
EX-99.1
b666epqrg gv994tc7
18 Aug 21
RepliCel Applies for Manufacturing Approval for its Collagen and Tissue Regeneration Cell Therapies
12:38pm
6-K
EX-99.1
5fom g05d
1 Dec 14
RepliCel Life Sciences Receives Health Canada Clearance for Clinical Trial in Patients with Chronic Achilles Tendinosis
12:00am
6-K
jleio
22 Mar 11
Current report (foreign)
12:00am
6-K
EX-99
3gc6is9jqk
6 Jun 13
Replicel and Shiseido Announce Collaboration and Technology Transfer Framework Agreement and Exclusive Geographic Technology License
12:00am
6-K
EX-99
8xltglkahny
6 Jun 13
Replicel and Shiseido Announce Collaboration and Technology Transfer Framework Agreement and Exclusive Geographic Technology License
12:00am
6-K
EX-99.4
6svo7gj6l99ctp3
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.4
jeiav eimfvdc2
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
xng2mseolm9n 10gos
16 Apr 07
Current report (foreign)
12:00am